IBD (Crohn’s and UC)

Revolutionary ‘Inverse Vaccine’ Offers Hope for Autoimmune Disease Treatment

A research team has developed an innovative “inverse vaccine” that could potentially treat autoimmune diseases, including multiple sclerosis (MS), type 1 diabetes, rheumatoid arthritis, and Crohn’s disease. This groundbreaking approach could offer more specificity in treatment, minimizing side effects and enhancing patient safety compared to current treatments that broadly suppress the immune system.

Read More »

Microbiome: Therapeutic Implications, Killarney Conference

An interdisciplinary group of scientists and physicians presented largely unpublished microbiome research at the 2019 Keystone Symposium in an effort to share, inspire, and provoke new ways of thinking. Certain autoimmune diseases, such as ulcerative colitis and type 1 diabetes, exhibit microbiomes that differ from those of healthy individuals.

Read More »

Digestive Disease Week (DDW) San Diego Conference

The May 2019 DDW Conference in San Diego, California, supported the largest international gathering of top physicians, researchers, and industry leaders in the fields of gastroenterology, endoscopy, hepatology, and gastrointestinal surgery. They discussed advancements in autoimmune and other diseases related to the gastrointestinal system, as well as what the future holds for diagnosing and treating these types of conditions.

Read More »